<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Yuan X</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Knee osteoarthritis (KOA) is a chronic degenerative bone metabolic disease that primarily affects older adults, leading to chronic pain and disability that affect patients' daily activities. Electroacupuncture (EA) is a commonly used method for the treatment of chronic pain in clinical practice. Previous studies indicate that the endocannabinoid system is involved in EA analgesia, but whether endocannabinopeptide VD-hemopressin (α) and RVD-hemopressin (α) derived from hemoglobin chains are involved in EA analgesia is unclear.&lt;h4>Methods&lt;/h4>RNA-seq technology was used to screen which genes involved in EA analgesia. The expression of hemoglobin α chain and 26S proteasome were determined by Western blotting. The level of VD-hemopressin (α) and RVD-hemopressin (α) were me</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1439448</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11473328</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain.</pubmed_title><pmcid>PMC11473328</pmcid><pubmed_authors>Baba SS</pubmed_authors><pubmed_authors>Yi H</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Huo F</pubmed_authors><pubmed_authors>Jia H</pubmed_authors><pubmed_authors>Yuan X</pubmed_authors><pubmed_authors>Hou X</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Li M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain.</name><description>&lt;h4>Introduction&lt;/h4>Knee osteoarthritis (KOA) is a chronic degenerative bone metabolic disease that primarily affects older adults, leading to chronic pain and disability that affect patients' daily activities. Electroacupuncture (EA) is a commonly used method for the treatment of chronic pain in clinical practice. Previous studies indicate that the endocannabinoid system is involved in EA analgesia, but whether endocannabinopeptide VD-hemopressin (α) and RVD-hemopressin (α) derived from hemoglobin chains are involved in EA analgesia is unclear.&lt;h4>Methods&lt;/h4>RNA-seq technology was used to screen which genes involved in EA analgesia. The expression of hemoglobin α chain and 26S proteasome were determined by Western blotting. The level of VD-hemopressin (α) and RVD-hemopressin (α) were me</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-04T13:53:35.985Z</modification><creation>2025-04-04T13:53:35.985Z</creation></dates><accession>S-EPMC11473328</accession><cross_references><pubmed>39411061</pubmed><doi>10.3389/fphar.2024.1439448</doi></cross_references></HashMap>